CompanyVivera Pharmaceuticals, Inc.
United States of America
Vivera Pharmaceuticals is an innovative, science-driven pharmaceutical company located in Southern California. The Company has global exclusivity to license the patented and patent-pending TABMELT™ sublingual drug delivery system for pharmaceutical use and holds its own issued patents on ZICOH™, an electronic, dose-controlled medical device. With multiple divisions, including its pharmaceutical, neurosciences, medical technology, biosciences, and advanced diagnostics divisions, Vivera Pharma...
Private/Public:
private
Phone:1.844.484.8372
Website:https://www.viverapharmaceuticals.com/
Address:4533 MacArthur Blvd #5049 Newport Beach, CA 92660 , United States of America
Product Groups
For Services/Products
Diagnostics
Diagnostic Product Offerings
Diagnostic Testing Services - Genomic/Non-genomic
United States of America
- (25.May.2022) Vivera Receives 3rd U.S. Patent Allowance for ZICOH Drug Delivery Device
- (17.May.2022) Vivera Partners With NINDS of NIH to Identify Potential Stuttering Treatments
- (09.Mar.2022) Will Recent $32 Billion in Opioid Settlements Prevent Addiction - Vivera Has the Answer
- (01.Mar.2022) Vivera Engages Star Legal Team to Lead $500 Million Lawsuit Against USA Today
- (14.Jan.2022) Vivera Pharmaceuticals Issues Statement Regarding LuSys Laboratories COVID-19 Tests
- (11.Jan.2022) Vivera Appoints Donald d'Ambrosio as Chief Financial Officer
- (03.Dec.2021) Vivera to Provide COVID-19 Testing at No-Cost at Univision Toy Drive
- (02.Dec.2021) Vivera Named COVID-19 Testing Partner for the 2021 Indigenous Bowl
- (23.Nov.2021) Vivera Announces Launch of New Testing Software, LabPort
- (11.Nov.2021) Vivera Pharmaceuticals Offers No-Cost COVID-19 Testing to LAPD and LAFD
- (26.Oct.2021) Vivera Pharmaceuticals Announces New BioSciences Division Focused on Research and Development in Drug Delivery
- (21.Sep.2021) Vivera Pharmaceuticals Collaborates With DoctorsOne Healthcare Systems and Manny Pacquiao Foundation for Joint Vaccine Initiative in Underserved SoCal Communities
- (14.Sep.2021) Vivera Pharmaceuticals Joins Forces With DoctorsOne Healthcare Systems and Manny Pacquiao Foundation for Vaccine Campaign in Underserved SoCal Communities
- (09.Sep.2021) $500 Million Defamation Lawsuit Against USA Today and Its Executives Continues as Vivera Receives More Favorable Decisions
- (27.Aug.2021) ZICOH Technology by Vivera Granted Second U.S. Patent (US 11,090,449) for Smart Inhaler Device
- (20.Aug.2021) Vivera Pharmaceuticals Receives U.S. Patent (US 11,083,850) for ZICOH
- (28.Jul.2021) Vivera Pharmaceuticals Responds to New Safety Protocols With Expanded Access to COVID-19 Testing, Vaccines, and Personal Protective Equipment
- (30.Jun.2021) Vivera Pharmaceuticals Partners With Areum Bio LLC and Access Bio, Inc. To Expand the National Distribution of Emergency Use Authorized COVID-19 Rapid Tests